Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, LiVolsi VA, Papotti MG, Sobrinho-Simoes M, Tallini G, Mete O (2022) Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocr Pathol 33 (1):27-63. https://doi.org/10.1007/s12022-022-09707-3

Article  PubMed  Google Scholar 

Volante M, Collini P, Nikiforov YE, Sakamoto A, Kakudo K, Katoh R, Lloyd RV, LiVolsi VA, Papotti M, Sobrinho-Simoes M, Bussolati G, Rosai J (2007) Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 31 (8):1256-1264. https://doi.org/10.1097/PAS.0b013e3180309e6a

Article  PubMed  Google Scholar 

Ricardo V. Lloyd RYO, Günter Klöppel, Juan Rosai (2017) WHO Classification of Tumours of Endocrine Organs. 4th edn. International Agency for Research on Cancer, Lyon

Asioli S, Erickson LA, Righi A, Jin L, Volante M, Jenkins S, Papotti M, Bussolati G, Lloyd RV (2010) Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression. Mod Pathol 23 (9):1269-1278. https://doi.org/10.1038/modpathol.2010.117

Article  PubMed  Google Scholar 

Tallini G (2011) Poorly differentiated thyroid carcinoma. Are we there yet? Endocr Pathol 22 (4):190–194. https://doi.org/10.1007/s12022-011-9176-5

Gnemmi V, Renaud F, Do Cao C, Salleron J, Lion G, Wemeau JL, Copin MC, Carnaille B, Leteurtre E, Pattou F, Aubert S (2014) Poorly differentiated thyroid carcinomas: application of the Turin proposal provides prognostic results similar to those from the assessment of high-grade features. Histopathology 64 (2):263-273. https://doi.org/10.1111/his.12246

Article  PubMed  Google Scholar 

Ibrahimpasic T, Ghossein R, Shah JP, Ganly I (2019) Poorly Differentiated Carcinoma of the Thyroid Gland: Current Status and Future Prospects. Thyroid 29 (3):311-321. https://doi.org/10.1089/thy.2018.0509

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hiltzik D, Carlson DL, Tuttle RM, Chuai S, Ishill N, Shaha A, Shah JP, Singh B, Ghossein RA (2006) Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer 106 (6):1286-1295. https://doi.org/10.1002/cncr.21739

Article  PubMed  Google Scholar 

Wong KS, Dong F, Telatar M, Lorch JH, Alexander EK, Marqusee E, Cho NL, Nehs MA, Doherty GM, Afkhami M, Barletta JA (2021) Papillary Thyroid Carcinoma with High-Grade Features Versus Poorly Differentiated Thyroid Carcinoma: An Analysis of Clinicopathologic and Molecular Features and Outcome. Thyroid 31 (6):933-940. https://doi.org/10.1089/thy.2020.0668

Article  CAS  PubMed  Google Scholar 

Xu B, David J, Dogan S, Landa I, Katabi N, Saliba M, Khimraj A, Sherman EJ, Tuttle RM, Tallini G, Ganly I, Fagin JA, Ghossein RA (2022) Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 cases. Histopathology 80 (2):322-337. https://doi.org/10.1111/his.14550

Article  PubMed  Google Scholar 

Na HY, Yu HW, Kim W, Moon JH, Ahn CH, Choi SI, Kim YK, Choi JY, Park SY (2022) Clinicopathological indicators for TERT promoter mutation in papillary thyroid carcinoma. Clin Endocrinol (Oxf) 97 (1):106-115. https://doi.org/10.1111/cen.14728

Article  CAS  PubMed  Google Scholar 

Mete O, Asa SL (2011) Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation. Mod Pathol 24 (12):1545-1552. https://doi.org/10.1038/modpathol.2011.119

Article  PubMed  Google Scholar 

LiVolsi VA, Merino MJ (1994) Worrisome histologic alterations following fine-needle aspiration of the thyroid (WHAFFT). Pathol Annu 29 ( Pt 2):99-120

PubMed  Google Scholar 

Mahul B. Amin SBE, Frederick L. Greene, David R. Byrd, Robert K. Brookland, Mary Kay Washington, Jeffrey E. Gershenwald, Carolyn C. Compton, Kenneth R. Hess, Daniel C. Sullivan, J. Milburn Jessup, James D. Brierley, Lauri E. Gaspar, Richard L. Schilsky, Charles M. Balch, David P. Winchester, Elliot A. Asare, Martin Madera, Donna M. Gress, Laura R. Meyer (2018) AJCC Cancer Staging Manual (8th edition). 8th edition edn. Springer, New York

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L (2016) 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26 (1):1-133. https://doi.org/10.1089/thy.2015.0020

Article  PubMed  PubMed Central  Google Scholar 

Packham D, Ward RL, Ap Lin V, Hawkins NJ, Hitchins MP (2009) Implementation of novel pyrosequencing assays to screen for common mutations of BRAF and KRAS in a cohort of sporadic colorectal cancers. Diagn Mol Pathol 18 (2):62-71. https://doi.org/10.1097/PDM.0b013e318182af52

Article  CAS  PubMed  Google Scholar 

Kang SH, Pyo JY, Yang SW, Hong SW (2013) Detection of BRAF V600E mutation with thyroid tissue using pyrosequencing: comparison with PNA-clamping and real-time PCR. Am J Clin Pathol 139 (6):759-764. https://doi.org/10.1309/AJCPN3ULH6YWBHPH

Article  CAS  PubMed  Google Scholar 

Xu B, Ghossein R (2020) Poorly differentiated thyroid carcinoma. Semin Diagn Pathol 37 (5):243-247. https://doi.org/10.1053/j.semdp.2020.03.003

Article  PubMed  Google Scholar 

Akslen LA (1993) Prognostic importance of histologic grading in papillary thyroid carcinoma. Cancer 72 (9):2680-2685. https://doi.org/10.1002/1097-0142(19931101)72:9<2680::aid-cncr2820720926>3.0.co;2-d

Article  CAS  PubMed  Google Scholar 

Akslen LA, LiVolsi VA (2000) Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma. Cancer 88 (8):1902-1908

Article  CAS  PubMed  Google Scholar 

Xu B, Ibrahimpasic T, Wang L, Sabra MM, Migliacci JC, Tuttle RM, Ganly I, Ghossein R (2016) Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas. Thyroid 26 (11):1588-1597. https://doi.org/10.1089/thy.2016.0247

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thompson LDR (2023) High Grade Differentiated Follicular Cell-Derived Thyroid Carcinoma Versus Poorly Differentiated Thyroid Carcinoma: A Clinicopathologic Analysis of 41 Cases. Endocr Pathol 34 (2):234-246. https://doi.org/10.1007/s12022-023-09770-4

Article  CAS  PubMed  Google Scholar 

Musholt TJ, Musholt PB (2015) Molecular genetic markers for thyroid FNAB. Established assays and future perspective. Nuklearmedizin 54 (3):94-100

PubMed  Google Scholar 

Landa I, Ibrahimpasic T, Boucai L, Sinha R, Knauf JA, Shah RH, Dogan S, Ricarte-Filho JC, Krishnamoorthy GP, Xu B, Schultz N, Berger MF, Sander C, Taylor BS, Ghossein R, Ganly I, Fagin JA (2016) Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J Clin Invest 126 (3):1052-1066. https://doi.org/10.1172/JCI85271

Article  PubMed  PubMed Central  Google Scholar 

Bournaud C, Descotes F, Decaussin-Petrucci M, Berthiller J, de la Fouchardiere C, Giraudet AL, Bertholon-Gregoire M, Robinson P, Lifante JC, Lopez J, Borson-Chazot F (2019) TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma. Eur J Cancer 108:41-49. https://doi.org/10.1016/j.ejca.2018.12.003

Article  CAS  PubMed  Google Scholar 

Liu X, Bishop J, Shan Y, Pai S, Liu D, Murugan AK, Sun H, El-Naggar AK, Xing M (2013) Highly prevalent TERT promoter mutations in aggressive thyroid cancers. Endocr Relat Cancer 20 (4):603-610. https://doi.org/10.1530/ERC-13-0210

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song YS, Lim JA, Choi H, Won JK, Moon JH, Cho SW, Lee KE, Park YJ, Yi KH, Park DJ, Seo JS (2016) Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients. Cancer 122 (9):1370-1379. https://doi.org/10.1002/cncr.29934

Article  CAS  PubMed  Google Scholar 

Bichoo RA, Mishra A, Kumari N, Krishnani N, Chand G, Agarwal G, Agarwal A, Mishra SK (2019) Poorly differentiated thyroid carcinoma and poorly differentiated area in differentiated thyroid carcinoma: is there any difference? Langenbecks Arch Surg 404 (1):45-53. https://doi.org/10.1007/s00423-019-01753-6

Article  PubMed  Google Scholar 

Wreesmann VB, Nixon IJ, Rivera M, Katabi N, Palmer F, Ganly I, Shaha AR, Tuttle RM, Shah JP, Patel SG, Ghossein RA (2015) Prognostic value of vascular invasion in well-differentiated papillary thyroid carcinoma. Thyroid 25 (5):503-508. https://doi.org/10.1089/thy.2015.0052

Article  CAS  PubMed  PubMed Central  Google Scholar 

Furlan JC, Bedard YC, Rosen IB (2004) Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas. J Am Coll Surg 198 (3):341-348. https://doi.org/10.1016/j.jamcollsurg.2003.11.012

Article  PubMed  Google Scholar 

Cao J, Hu JL, Chen C, Wang QL, Fang XH, Zhang Y, Ge MH (2016) Vascular invasion is an independent prognostic factor for distant recurrence-free survival in papillary thyroid carcinoma: a matched-case comparative study. J Clin Pathol 69 (10):872-877. https://doi.org/10.1136/jclinpath-2015-203547

Article  CAS  PubMed  Google Scholar 

Suh YJ, Kwon H, Kim SJ, Choi JY, Lee KE, Park YJ, Park DJ, Youn YK (2015) Factors Affecting the Locoregional Recurrence of Conventional Papillary Thyroid Carcinoma After Surgery: A Retrospective Analysis of 3381 Patients. Ann Surg Oncol 22 (11):3543-3549. https://doi.org/10.1245/s10434-015-4448-9

Article  PubMed  Google Scholar 

Falvo L, Catania A, D'Andrea V, Marzullo A, Giustiniani MC, De Antoni E (2005) Prognostic importance of histologic vascular invasion in papillary thyroid carcinoma. Ann Surg 241 (4):640-646. https://doi.org/10.1097/01.sla.0000157317.60536.08

Article  PubMed  PubMed Central  Google Scholar 

Kruijff S, Petersen JF, Chen P, Aniss AM, Clifton-Bligh RJ, Sidhu SB, Delbridge LW, Gill AJ, Learoyd D, Sywak MS (2014) Patterns of structural recurrence in papillary thyroid cancer. World J Surg 38 (3):653-659. https://doi.org/10.1007/s00268-013-2286-0

Article  PubMed  Google Scholar 

Ito Y, Kudo T, Kobayashi K, Miya A, Ichihara K, Miyauchi A (2012) Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up. World J Surg 36 (6):1274-1278. https://doi.org/10.1007/s00268-012-1423-5

Article  PubMed  Google Scholar 

Baek SK, Jung KY, Kang SM, Kwon SY, Woo JS, Cho SH, Chung EJ (2010) Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma. Thyroid 20 (2):147-152. https://doi.org/10.1089/thy.2008.0243

Article